HIV-Nef and AIDS pathogenesis: Are we barking up the wrong tree?

Trends in Microbiology

Volumn 19, Issue 9, 2011, Pages 435-440

  Baur, Andreas S ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ESCRT PROTEIN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; CELL VACUOLE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENDOCYTOSIS; EXOCYTOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; RECEPTOR UPREGULATION; REVIEW; UBIQUITINATION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ENDOCYTOSIS; EXOCYTOSIS; HIV; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80052161955     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2011.06.002     Document Type: Review

References (60)

1. Kestler H.W., et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 65:651-662.
2. Deacon N.J., et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995, 270:988-991.
3. Silvestri G., et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003, 18:441-452.
4. Hanna Z., et al. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 1998, 95:163-175.
5. Stoddart C.A., et al. Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. J. Virol. 2003, 77:2124-2133.
6. Iafrate A.J., et al. Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo. J. Virol. 2000, 74:9836-9844.
7. Garcia J.V., Miller A.D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 1991, 350:508-511.
8. Schwartz O., et al. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 1996, 2:338-342.
9. Piguet V., et al. The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors. Immunol. Rev. 1999, 168:51-63.
10. Noviello C.M., et al. Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit. J. Virol. 2008, 82:1249-1258.
11. Rhee S.S., Marsh J.W. Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 1994, 68:5156-5163.
12. Schaefer M.R., et al. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells. PLoS. Pathog. 2008, 4:e1000131.
13. daSilva L.L., et al. Human immunodeficiency virus type 1 Nef protein targets CD4 to the multivesicular body pathway. J. Virol. 2009, 83:6578-6590.
14. Madrid R., et al. Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity. J. Biol. Chem. 2005, 280:5032-5044.
15. Stumptner-Cuvelette P., et al. Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase. Mol. Biol. Cell 2003, 14:4857-4870.
16. Gratton S., et al. Molecular analysis of the cytoplasmic domain of CD4: overlapping but noncompetitive requirement for lck association and down-regulation by Nef. J. Immunol. 1996, 157:3305-3311.
17. Laguette N., et al. Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase. J. Virol. 2009, 83:7117-7128.
18. Thoulouze M.I., et al. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 2006, 24:547-561.
19. Muratori C., et al. Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe 2009, 6:218-230.
20. Stove V., et al. Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta. J. Virol. 2005, 79:11422-11433.
21. Michel N., et al. The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and Galphai signaling. Mol. Biol. Cell 2006, 17:3578-3590.
22. Marsh M., et al. Endocytic regulation of the T lymphocyte co-receptor proteins CD4 and CD8. Biochem. Soc. Trans. 1993, 21:703-706.
23. Baur A.S., et al. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 1997, 6:283-291.
24. Raiborg C., et al. Protein sorting into multivesicular endosomes. Curr. Opin. Cell Biol. 2003, 15:446-455.
25. Jin Y.J., et al. Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation. J. Immunol. 2008, 180:7878-7886.
26. Simmons A., et al. Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling. Immunity 2005, 23:621-634.
27. Yang P., Henderson A.J. Nef enhances c-Cbl phosphorylation in HIV-infected CD4+ T lymphocytes. Virology 2005, 336:219-228.
28. Fomina A.F., et al. Regulation of membrane trafficking and subcellular organization of endocytic compartments revealed with FM1-43 in resting and activated human T cells. Exp. Cell Res. 2003, 291:150-166.
29. Poteryaev D., et al. Identification of the switch in early-to-late endosome transition. Cell 2010, 141:497-508.
30. Jolly C., Sattentau Q.J. Regulated secretion from CD4+ T cells. Trends Immunol. 2007, 28:474-481.
31. Costa L.J., et al. Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. Retrovirology 2006, 3:33.
32. Blagoveshchenskaya A.D., et al. HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 2002, 111:853-866.
33. Swingler S., et al. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 2003, 424:213-219.
34. Swingler S., et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 1999, 5. 997-103.
35. Raymond A.D., et al. HIV type 1 Nef is released from infected cells in CD45+ microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res. Hum. Retroviruses 2010, 27:167-178.
36. Lenassi M., et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 2010, 11:110-122.
37. Lama J. The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr. HIV Res. 2003, 1:167-184.
38. Glushakova S., et al. CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4+ T-cell depletion in human lymphoid tissue ex vivo. J. Virol. 2001, 75:10113-10117.
39. Neri F., et al. CD4 down-regulation by the HIV-1 nef protein is dispensable for optimal output and functionality of viral particles in primary T cells. J. Gen. Virol. 2010, 92:141-150.
40. Sandrin V., Cosset F.L. Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. J. Biol. Chem. 2006, 281:528-542.
41. Schiavoni I., et al. HIV-1 Nef enhances both membrane expression and virion incorporation of Env products. A model for the Nef-dependent increase of HIV-1 infectivity. J. Biol. Chem. 2004, 279:22996-23006.
42. Goldsmith M.A., et al. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 1995, 69:4112-4121.
43. Schwartz O., et al. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 1995, 69:4053-4059.
44. Schindler M., et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006, 125:1055-1067.
45. Foster J.L., Garcia J.V. HIV-1 Nef: at the crossroads. Retrovirology 2008, 5:84.
46. Feldmann J., et al. Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression. J. Virol. 2009, 83:12968-12972.
47. Collins K.L., et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998, 391:397-401.
48. Agopian K., et al. CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable. Virology 2007, 358:119-135.
49. Sykulev Y., et al. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996, 4:565-571.
50. Zitvogel L., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 1998, 4:594-600.
51. Peche H., et al. Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Am. J. Transplant. 2006, 6:1541-1550.
52. Szajnik M., et al. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS. ONE 2010, 5:e11469.
53. Kim S.H., et al. MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner. J. Immunol. 2007, 179:2235-2241.
54. Bossi G., Griffiths G.M. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 1999, 5:90-96.
55. Xu X.N., et al. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 1997, 186:7-16.
56. Andersson J., et al. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 2005, 174:3143-3147.
57. Lamers S.L., et al. HIV-1 nef protein visits B-cells via macrophage nanotubes: a mechanism for AIDS-related lymphoma pathogenesis?. Curr. HIV Res. 2010, 8:638-640.
58. Qiao X., et al. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 2006, 7:302-310.
59. Atay S., et al. Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Am. J. Reprod. Immunol. 2011, 65:65-77.
60. Qazi K.R., et al. Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis. Thorax 2010, 65:1016-1024.